Evidence map›Paper›PMID 26150141›Full record

ArticleBMJ open2015

Development of a computerised decisions support system for renal risk drugs targeting primary healthcare.

Anders Helldén, Fadiea Al-Aieshy, Pia Bastholm-Rahmner, Ulf Bergman, Lars L Gustafsson, Hans Höök, Susanne Sjöviker, Anders Söderström, Ingegerd Odar-Cederlöf

Abstract read
In one paragraph

Article in BMJ open, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Anders HelldénDepartment of Clinical Pharmacology, Karolinska University Hospital, Stockholm, Sweden Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
Fadiea Al-AieshyDepartment of Clinical Pharmacology, Karolinska University Hospital, Stockholm, Sweden.
Pia Bastholm-RahmnerDivision of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden Department of Healthcare Development, Public Healthcare Administration, Stockholm County Council, Stockholm, Sweden.
Ulf BergmanDepartment of Clinical Pharmacology, Karolinska University Hospital, Stockholm, Sweden Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
Lars L GustafssonDepartment of Clinical Pharmacology, Karolinska University Hospital, Stockholm, Sweden Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
Hans HöökDepartment of Healthcare Development, Public Healthcare Administration, Stockholm County Council, Stockholm, Sweden.
Susanne SjövikerDepartment of Healthcare Development, Public Healthcare Administration, Stockholm County Council, Stockholm, Sweden.
Anders SöderströmVendelsö Healthcare Centre, Stockholm, Sweden.
Ingegerd Odar-CederlöfDepartment of Clinical Pharmacology, Karolinska University Hospital, Stockholm, Sweden Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo assess general practitioners (GPs) experience from the implementation and use of a renal computerised decision support system (CDSS) for drug dosing, developed for primary healthcare, integrated into the patient's electronic health record (EHR), and building on estimation of the patient's creatinine clearance (ClCG).

designQualitative research design by a questionnaire and a focus group discussion. SETTING AND

participantsEight GPs at two primary healthcare centres (PHCs).

interventionsThe GP at PHC 1, and the project group, developed and tested the technical solution of the CDSS. Proof-of-concept was tested by seven GPs at PHC 2. They also participated in a group discussion and answered a questionnaire. A web window in the EHR gave drug and dosage in relation to ClCG. Each advice was according to three principles: If? Why? Because. OUTCOME MEASURES: (1) The GPs' experience of 'easiness to use' and 'perceived usefulness' at PHC 2, based on loggings of use, answers from a questionnaire using a 5-point Likert scale, and answers from a focus group discussion. (2) The number of patients aged 65 years and older with an estimation of ClCG before and after the implementation of the CDSS.

resultsThe GPs found the CDSS fast, simple and easy to use. They appreciated the automatic presentation of the CICG status on opening the medication list, and the ability to actively look up specific drug recommendations in two steps. The CDSS scored high on the Likert scale. All GPs wanted to continue the use of the CDSS and to recommend it to others. The number of patients with an estimated ClCG increased 1.6-fold.

conclusionsAcceptance of the simple graphical interface of this push and pull renal CDSS was high among the primary care physicians evaluating this proof of concept. The graphical model should be useful for further development of renal decision support systems.

Indexed as

Primary Health CareAgedAged, 80 and overDecision Support Systems, ClinicalDrug Therapy, Computer-AssistedElectronic Health RecordsFemaleGeneral PractitionersHumansMaleRenal InsufficiencySurveys and QuestionnairesCLINICAL PHARMACOLOGYGERIATRIC MEDICINENEPHROLOGYPRIMARY CARE

Identifiers

PMID26150141
PMCPMC4499680

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.